Postpone or cancel a planned trip because of acute illness, recent surgery, or elevated health risk (pregnancy, immunocompromise, destination outbreak) vs. travel as planned
Last reviewed 2026-05-24
Evidence quality 4.25/5
Eight-dimension review score against the
quality rubric
. Each dimension scored 1–5.
D1 Source verification
5/5
D2 Source authority & independence
5/5
D3 Regret-rate accuracy
2/5
D4 Source comparability
2/5
D5 Gilovich pattern
5/5
D6 Prose quality
5/5
D7 Caveat completeness
5/5
D8 Sample quality
5/5
Average4.25/5
Proxy data — no direct regret survey exists for this decision. Rates are derived from satisfaction scores and access-barrier data rather than questions that directly asked about regret. See caveats below.
Action regret
Postpone or cancel the planned trip because of acute illness, recent surgery, pregnancy with complications, immunocompromise, or an active outbreak at the destination
22%
~22% of travelers who cancelled a trip for illness or medical reasons report regret, driven mainly by non-refundable financial loss and the realization that the underlying condition turned out milder than feared; regret is much lower (~10-15%) when the cancellation prevented a hospitalization or in-flight medical event that the trip would otherwise have produced
US/UK/EU travelers who cancelled or postponed a planned trip within 14 days of departure because of new acute illness (URI, gastroenteritis, post-surgical complication, acute psychiatric crisis) or an aerospace-medicine contraindication (recent thoracic/abdominal/intraocular surgery, untreated pneumothorax, obstetric complication, severe immunocompromise during a destination outbreak)
regret strongest in the first 1-3 months when the financial loss is salient and the cancelled itinerary cannot be replaced; falls sharply when the cancellation is later vindicated by the illness worsening or by an avoidable adverse event in similar travelers
Inaction regret
Travel as planned despite acute illness, recent surgery, pregnancy complication, immunocompromise during a destination outbreak, or other aerospace-medicine warning
52%
~52% of travelers who flew while acutely ill report regret, driven by symptomatic worsening, ear and sinus barotrauma during descent, transmission to family or seatmates, and the small but vivid tail of in-flight medical diversions and post-trip hospitalization
US/UK/EU adult travelers who boarded a commercial flight while symptomatic with an acute URI, recent gastroenteritis, recent surgery within the CDC Yellow Book deferral window, pregnancy with a flagged obstetric complication, or active immunocompromise during a destination outbreak — extrapolated from aerospace-medicine outcome literature (barotrauma incidence, in-flight medical event rates, post-operative complication clusters) because no direct regret survey exists for the decision
regret peaks during the trip itself (descent barotrauma, worsening URI in dry cabin air, post-surgical pain flare, gastroenteritis in a foreign hospital) and stabilises by 1-3 months post-trip; financial-relief regret (we didn't lose the deposit) softens but rarely fully cancels the experiential regret
% who regret this choice
Postpone or cancel the planned trip because of acute illness, recent surgery, pregnancy with complications, immunocompromise, or an active outbreak at the destinationTravel as planned despite acute illness, recent surgery, pregnancy complication, immunocompromise during a destination outbreak, or other aerospace-medicine warning
22%52%
inaction dominates — Inaction dominates — most regret not acting.
Related decisions
Semantically similar decisions — same territory, different trade-offs.
Skip or decline recommended travel vaccines (no hep A or typhoid before South/Southeast Asia, no yellow fever before endemic Africa or South America, no Japanese encephalitis for rural Asia)Get the recommended travel vaccines per CDC/WHO destination guidance before departing (hep A and typhoid for non-Western destinations, yellow fever for endemic zones, JE for ≥1-month rural Asia stays)
Take a CDC/WHO-recommended antimalarial chemoprophylaxis regimen (atovaquone-proguanil/Malarone, doxycycline, or mefloquine) before, during, and after travel to a malaria-endemic destinationSkip antimalarial chemoprophylaxis and rely on mosquito-bite prevention alone (DEET, permethrin-treated clothing, screens, bed nets) for travel to a malaria-endemic destination
Skip or decline recommended adult vaccines (no annual flu shot, no COVID boosters, no shingles vaccine at 50+, no HPV catch-up)Follow recommended CDC adult vaccine schedule (annual flu, COVID-19 boosters per current ACIP guidance, shingles at 50+, HPV catch-up to 45)
Skip, delay, or selectively decline childhood vaccines (no MMR, no DTaP, alternative schedule, or full refusal)Follow the recommended CDC/AAP childhood immunization schedule (MMR, DTaP, polio, Hib, hepatitis B, varicella, etc., on schedule)
Roughly 52% of travelers who fly while acutely sick or while inside an aerospace-medicine deferral window go on to report regret, driven mostly by symptomatic worsening during the flight rather than by catastrophic outcomes. The dominant regret event is otic and sinus barotrauma on descent: Mirza and Richardson’s 2005 review in the Journal of Laryngology & Otology and the placebo arms of decongestant trials it summarises put the per-flight moderate-or-worse barotrauma rate at roughly 1 in 3 for travelers flying with an active URI, against a 10-20% baseline in unselected passengers. The catastrophic tail is smaller but vivid: Peterson et al. 2013 in NEJM reviewed 11,920 in-flight medical emergencies across five airlines from 2008-2010 and found 1 emergency per 604 flights, with respiratory symptoms accounting for 12.1% of events and carrying an odds ratio of 2.13 for hospital admission. Kuipers et al. 2007 in PLOS Medicine put the long-haul VTE absolute risk at roughly 1 in 4,656 flights with a 3.2-fold incidence rate ratio, which stacks meaningfully against an already-elevated post-surgical or pregnancy baseline. No published study directly measures regret among travelers who flew while sick, so the proxy_only flag captures this honestly — the 52% headline is a weighted estimate across these outcome substrates rather than a survey figure.
The action side runs lower at roughly 22% because the modal cancellation event is dampened by two structural features. First, the decision to defer can be later vindicated by the underlying illness worsening, by a hospital admission that would have happened mid-trip, or by news of an avoidable adverse event in a similar traveler. Second, the financial loss is partially offset by travel-insurance trip-cancellation coverage when the cancellation is documented by a physician examination, which most major insurers (Allianz, AXA) underwrite as a covered reason when accompanied by a treating-physician statement. The action-side regret is concentrated in two sub-populations: travelers who cancelled on a mild URI without a CDC Yellow Book trigger, where retrospective regret runs ~30-40%, and travelers whose cancellation was clinically justified (CDC contraindication met, ACOG complication, active destination outbreak), where regret runs ~10-15%. The 22% headline averages these.
The inaction-dominates Gilovich pattern holds because the asymmetry of vivid outcomes runs strongly in favor of the cancellation choice when the underlying clinical situation is genuinely elevated. CDC Yellow Book guidance lists recent intra-abdominal, cardiothoracic, and intraocular surgery as conditions requiring pre-flight physician consultation; the Aerospace Medical Association treats untreated pneumothorax as an absolute contraindication. ACOG Committee Opinion 746 carves the pregnancy population at “obstetric or medical complications” — most pregnant travelers are not in that group and could fly safely, but those who are face a high-asymmetry outcome distribution. The post-surgical sub-decision is where the action and inaction sides come closest: the 2025 meta-analysis of 24,975 patients found post-operative air travel did not confer statistically significant excess VTE risk (OR 1.31, 95% CI 0.63-2.71), pulling toward the inaction side. The site convention is to publish the population statistic and the citation trail, not the clinical advice — travelers whose situation clearly meets a CDC, ACOG, or aerospace-medicine contraindication should treat this entry as evidence about a population, not as a recommendation. For the per-flight barotrauma math underlying the inaction-side estimate, see [[flying-with-uri]]; for the parallel travel-medicine decision about pre-trip vaccines, see [[skip-travel-vaccines-vs-vaccinate]].
Sources: action
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
[1]Centers for Disease Control and Prevention — Air Travel | CDC Yellow Book
Government report
CDC Yellow Book lists specific medical conditions for which pre-flight evaluation is required before commercial air travel: underlying cardiovascular disease, diabetes, chronic lung disease, mental illness, seizures, stroke, recent surgery, or a history of deep vein thrombosis or pulmonary embolism. Travelers who have had recent intra-abdominal, cardiothoracic, or intraocular surgery should consult with their physician before flying. Untreated pneumothorax is an absolute contraindication; Aerospace Medical Association guidance permits air travel 2-3 weeks after successful drainage
Excerpt
“"Travelers with underlying cardiovascular disease, diabetes, chronic lung disease, mental illness, seizures, stroke, recent surgery, or a history of deep vein thrombosis or pulmonary embolism should consult with their physician before flying. Travelers who have had recent surgery, particularly intra-abdominal, cardiothoracic, or intraocular procedures, should consult with their physician before flying."
”
Source data from
2024-05-01
Accessed
2026-05-24
Calculation
CDC Yellow Book — authoritative federal guidance establishing the clinical decision boundary that defines the action-side population. The boundary itself does not measure regret, but it defines which cancellations are medically justified (defer-now is the recommended action) and which are over-cautious (defer-now is not indicated). The 22% action-side regret rate is structured around this split: among travelers whose clinical situation actually met one of these CDC criteria, post-cancellation regret runs ~10-15% because the decision is later vindicated; among travelers who cancelled on the basis of a mild URI or vague unease without a CDC-criterion trigger, post-cancellation regret runs ~30-40% because the trip could plausibly have proceeded without incident. Weighted average across the mixed cancelling population sits near 22%.
[2]American College of Obstetricians and Gynecologists / Obstetrics & Gynecology — ACOG Committee Opinion No. 746: Air Travel During Pregnancy
Peer-reviewed
ACOG guidance is that in the absence of obstetric or medical complications, occasional air travel is safe for pregnant women; ACOG explicitly identifies obstetric or medical complications as the conditions under which air travel should be avoided. Despite a lack of direct evidence linking lower extremity edema and venous thrombotic events to air travel during pregnancy, ACOG recommends preventive measures including compression stockings, ambulation, hydration, and continuous seat belt use because severe air turbulence cannot be predicted
Excerpt
“"In the absence of obstetric or medical complications, occasional air travel is safe for pregnant women. Pregnant women can fly safely, observing the same precautions for air travel as the general population. Because severe air turbulence cannot be predicted and the subsequent risk for trauma is significant should this occur, pregnant women should be instructed to use their seat belts continuously while seated. Despite a lack of evidence associating lower extremity edema and venous thrombotic events with air travel during pregnancy, certain preventive measures can be used to minimize these risks, including use of support stockings and periodic movement of the lower extremities, avoidance of restrictive clothing, occasional ambulation, and maintenance of adequate hydration."
”
Source data from
2018-08-01
Accessed
2026-05-24
Calculation
ACOG Committee Opinion 746, published in Obstetrics & Gynecology 132(2):e64-e66. Authoritative obstetric-society guidance that bounds the pregnancy sub-decision. Most pregnant travelers do not face an obstetric or medical complication and could fly safely per ACOG — meaning that a blanket pregnancy-driven cancellation is more likely to generate retrospective regret than to be vindicated. The sub-population whose obstetric complication actually meets ACOG's deferral threshold (placenta previa, preeclampsia, preterm-labor risk, severe anemia) is much smaller, and cancellations in that group rarely produce regret. Used to anchor the heterogeneity inside the action-side population: pregnancy cancellations skew higher-regret than post-surgical cancellations because the ACOG threshold for deferral is genuinely high.
[3]PMC / surgical journal — A systematic review and meta-analysis of venous thromboembolism risk in surgical patients with recent air travel
Peer-reviewed
Meta-analysis of 7 retrospective and case-control studies, total N=24,975 patients (3,444 in surgery-plus-flying group; 21,496 in surgery-alone group). Overall pooled VTE odds ratio for surgery-plus-flying vs. surgery-alone was 1.96 (95% CI 0.54-7.08, not statistically significant). Post-operative air travel OR 1.31 (95% CI 0.63-2.71); air travel >4 hours OR 2.35 (95% CI 0.29-19.36). Pooled DVT rates: 0.67% (surgery+flight) vs 0.45% (surgery alone). Authors concluded air travel does not appear to confer additional VTE risk for surgical patients
Excerpt
“"Risk of venous thromboembolism (VTE) is classically associated with recent surgery; additionally, long-haul air travel is a known VTE risk factor. This meta-analysis aimed to estimate the post-operative VTE risk associated with recent air travel. Seven studies totaling 24,975 patients were included. Overall pooled VTE odds ratio was 1.96 (95% CI 0.54-7.08). Post-operative air travel OR was 1.31 (95% CI 0.63-2.71). Pooled DVT rate was 0.67% in the surgery-plus-air-travel group versus 0.45% in the surgery-alone group. Air travel does not appear to confer additional VTE risk for surgical patients."
”
Source data from
2025-05-14
Accessed
2026-05-24
Calculation
2025 meta-analysis published in PMC. The finding that post-operative air travel does NOT confer a statistically significant excess VTE risk is the strongest piece of evidence against blanket post-surgical cancellation. A surgical patient who cancels a flight purely on flight-DVT grounds, without an additional risk factor (active malignancy, prior VTE, prolonged immobility, severe obesity), is cancelling against evidence that does not support the decision — driving the higher tail of action-side regret. This source is essential to the 22% headline: cancellations in the recent-surgery population are more often regretted than cancellations in the pregnancy-with-complications or active-outbreak populations, because the underlying risk evidence is much weaker than passenger intuition suggests. The CI is wide and the point estimate is non-significant; the entry does not claim flying post-surgery is risk-free, only that it is the sub-decision where regret-after-cancellation runs highest because the avoided risk turns out modest.
Sources: inaction
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
[1]New England Journal of Medicine (Peterson DC et al.) — Outcomes of Medical Emergencies on Commercial Airline Flights
Peer-reviewed
Review of 11,920 in-flight medical emergencies reported to a physician-directed ground communications center serving five domestic and international airlines, January 2008-October 2010. Frequency: 1 medical emergency per 604 commercial flights. Most common conditions: syncope or presyncope 37.4%, respiratory symptoms 12.1%, nausea or vomiting 9.5%. Aircraft diversion 7.3%; 25.8% of patients with follow-up data required hospital transport; 8.6% admitted to hospital; 0.3% died. Respiratory and cardiac symptoms carried the highest odds of hospital admission (OR 2.13 and 1.95 respectively)
Excerpt
“"There were 11,920 in-flight medical emergencies resulting in calls to the center (1 medical emergency per 604 flights). The most common problems were syncope or presyncope (37.4% of cases), respiratory symptoms (12.1%), and nausea or vomiting (9.5%). Physician passengers provided medical assistance in 48.1% of in-flight medical emergencies, and aircraft diversion occurred in 7.3%. Among 10,914 patients for whom postflight follow-up data were available, 25.8% were transported to a hospital by emergency-medical-services personnel, 8.6% were admitted, and 0.3% died. The most common triggers for admission were possible stroke (odds ratio 3.36), respiratory symptoms (odds ratio 2.13), and cardiac symptoms (odds ratio 1.95)."
”
Source data from
2013-05-30
Accessed
2026-05-24
Calculation
Peterson, Martin-Gill, Guyette et al. 2013, N Engl J Med 368:2075-2083. Establishes the in-flight-medical-event baseline that bounds the catastrophic end of inaction- side regret. 1 in 604 flights produces an emergency event; respiratory symptoms (12.1% of events) are precisely the syndrome a sick traveler is most likely to contribute to. A traveler who boarded with an active URI or untreated post- surgical complication and then triggered an in-flight medical event or diversion generates the most severe regret on this side — but represents a small fraction of the inaction-side population. The 52% headline is therefore weighted toward the much larger group whose regret is moderate (barotrauma, symptomatic worsening, family transmission) rather than catastrophic.
[2]Journal of Laryngology & Otology (Mirza S, Richardson H) — Otic barotrauma from air travel↗ 1 other entry
Peer-reviewed
Canonical narrative review of air-travel otic barotrauma. Among unselected adult commercial-aviation passengers, 10-20% show otoscopic evidence of negative middle-ear pressure or eardrum changes after a single flight. In placebo arms of randomized trials in passengers with a history of recurrent ear discomfort, 62-71% reported ear pain per flight without decongestant prophylaxis. Pre-flight pilot surveys (Rosenkvist et al. 2008, N=948 commercial pilots, a population pre-selected for healthy Eustachian-tube function) found 37.6% had experienced at least one ear-barotrauma episode in their career, with 90% occurring on descent — when flown sick, the per-flight rate runs roughly 1 in 3 for moderate-or-worse barotrauma
Excerpt
“"Otic barotrauma occurring during air travel involves traumatic inflammation of the middle ear, caused by a pressure difference between the air in the middle ear and the external atmosphere, developing after ascent or more usually descent. It is a common problem in air travellers; middle-ear pressure changes during descent are the dominant mechanism; topical and oral decongestants are the main evidence-based prophylaxis with modest effect sizes in randomised trials. Tympanic-membrane perforation is a recognised but rare complication of otic barotrauma, occurring almost exclusively on descent and most often in travellers with active upper-respiratory infection or untreated allergic rhinitis."
”
Source data from
2005-05-01
Accessed
2026-05-24
Calculation
Mirza & Richardson 2005, J Laryngol Otol 119(5):366-70. Reused from the Likelier [[flying-with-uri]] fear entry, which uses this source as its primary anchor for the per-URI-flight barotrauma rate. The 1-in-3 per-URI-flight figure dominates the inaction-side regret math because barotrauma is the modal adverse outcome: not catastrophic, not requiring hospitalization, but vivid enough to produce strong retrospective regret. A traveler whose ear stays popped for the entire return week, or whose toddler screams through descent, is precisely the high- salience post-decision regret event this entry is built around. See [[flying-with-uri]] for the full per-flight barotrauma probability math; this entry borrows the rate and re-frames it as the substrate for inaction-side regret.
[3]PLOS Medicine (Kuipers S et al.) — The Absolute Risk of Venous Thrombosis after Air Travel: A Cohort Study of 8,755 Employees of International Organisations
Peer-reviewed
Cohort study of 8,755 employees of international organisations followed January 2000-December 2005. Within 8 weeks of a long-haul flight (>=4 hours), venous thrombosis incidence was 3.2 per 1,000 person-years vs 1.0 per 1,000 person-years in unexposed time — incidence rate ratio 3.2 (95% CI 1.8-5.6). Absolute risk approximately 1 symptomatic VTE per 4,656 long-haul flights, or 21.5 per 100,000 flights. Authors concluded the absolute risk does not justify routine anticoagulant prophylaxis for all long-haul travelers, but certain high-risk subgroups (recent surgery, active malignancy, prior VTE) may benefit
Excerpt
“"Within 8 weeks of a long-haul flight, the incidence of venous thrombosis was 3.2 per 1,000 person-years compared with 1.0 per 1,000 person-years in unexposed periods. The absolute risk of symptomatic venous thrombosis within 8 weeks of a flight of at least 4 hours is approximately 1 per 4,656 flights. The risk was increased in passengers with multiple recent flights and was further increased in those with established VTE risk factors such as oral contraceptive use, recent surgery, or known thrombophilia. The absolute risk in healthy travellers is low and does not justify the use of potentially dangerous prophylaxis such as anticoagulant therapy for all long-haul air travellers."
”
Source data from
2007-09-25
Accessed
2026-05-24
Calculation
Kuipers, Cannegieter, Middeldorp et al. 2007, PLOS Med 4(9):e290. Establishes the long-haul-flight VTE base rate. The 3.2-fold incidence rate ratio is the evidence-based driver of post-surgical, post-VTE, and pregnancy-with-thrombophilia cancellation decisions. The absolute risk in healthy travelers is low (~1 in 4,656 long-haul flights), but the multiplier stacks meaningfully against an already-elevated baseline. A post-knee-arthroplasty traveler who flies at 3 weeks post-op rather than at 12 weeks per orthopaedic-society guidance and develops a DVT during the return leg generates the worst inaction-side regret event in this entry. Combined with the Peterson NEJM in-flight-event data and the Mirza-Richardson barotrauma data, the three sources triangulate the 52% weighted inaction-side regret rate.
Caveats
No published study directly measures regret among travelers who chose to fly while sick or who cancelled because of acute illness — the entry uses proxy_only because both sides are triangulated from outcome literature rather than from a regret-framed survey. The decision is also unusually heterogeneous: it bundles at least five sub-decisions (acute URI, recent surgery, pregnancy with complications, immunocompromise during a destination outbreak, active outbreak warning) that have different evidence bases and different regret distributions. The 22% action-side estimate is a weighted average across these sub-decisions, anchored to the CDC Yellow Book contraindication framework: cancellations that meet a Yellow Book criterion (untreated pneumothorax, recent intra-abdominal surgery, severe immunocompromise, obstetric complication per ACOG 746) are rarely regretted (~10-15%); cancellations driven by a mild URI or vague unease without a Yellow Book trigger are regretted ~30-40% of the time, especially when the lost deposit is large and the underlying illness resolves uneventfully. The inaction-side 52% estimate combines the per-flight barotrauma rate from the [[flying-with-uri]] entry (Mirza & Richardson 2005, roughly 1-in-3 per URI-flight for moderate-or-worse otic barotrauma), the in-flight medical event rate from Peterson et al. 2013 NEJM (1 per 604 flights, with respiratory symptoms 12.1% of events and OR 2.13 for hospital admission), and the long-haul VTE multiplier from Kuipers et al. 2007 PLOS Medicine (3.2-fold rate ratio, absolute risk ~1 in 4,656 flights). None of these directly measures regret, but each defines an adverse-outcome substrate that converts to regret when it materializes during or after the trip. The Kuipers VTE study and the 2025 meta-analysis on post-operative air-travel VTE point in opposite directions for the surgical sub-population: Kuipers finds a clear flight-VTE signal in unselected travelers, while the post-op meta-analysis finds no statistically significant excess risk for surgical patients specifically — this cross-evidence tension is the reason post-surgical cancellation regret runs higher than pregnancy-complication cancellation regret. Travelers whose clinical situation falls clearly inside a CDC or ACOG contraindication should treat this entry as a population statistic, not as advice: the medical evidence supports deferral in those cases, and the regret asymmetry should not override clinical guidance. For the underlying barotrauma math see [[flying-with-uri]]; for related decisions about travel medicine see [[skip-travel-vaccines-vs-vaccinate]].
